Literature DB >> 16437670

Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.

Filiz Akyüz1, Nuray Polat, Sabahattin Kaymakoglu, Nevzat Aksoy, Kadir Demir, Fatih Beşişik, Selim Badur, Yilmaz Cakaloglu, Atilla Okten.   

Abstract

AIM: To evaluate whether the cytokine responses in liver and serum differ in chronic hepatitis C patients with normal and high alanine aminotransferase (ALT) levels.
METHODS: Thirty-three (16 with normal ALT level as group 1 and 17 with elevated ALT level as group 2) patients infected with genotype 1b hepatitis C virus (HCV) were examined. Liver infiltrating lymphomononuclear cells (LILMCs) were isolated from liver biopsy by collagenase type 1 and stimulated with phytohemagglutinin and interleukin 2 (IL-2). IL-10, IL-12, interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) were determined in serum and LILMCs by ELISA.
RESULTS: Serum cytokine levels were similar in both groups (P>0.05). Stimulated IFN-gamma and TNF-alpha levels in LILMCs were increased in both groups. IL-12 and IL-10 levels stimulated with IL-2 were higher in group 1 than in group 2 (P = 0.023). Histological activity index (HAI) and stage had a negative correlation with TNF-alpha and IFN-gamma levels in group 2.
CONCLUSION: Increased T-helper type 2 (Th2) cytokine response may regress inflammatory and biochemical activity. Progression of histological abnormalities in persons with elevated ALT probably depends on insufficient Th2 cytokine response, which does not balance Th1 cytokine response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437670      PMCID: PMC4723403          DOI: 10.3748/wjg.v11.i45.7188

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

Review 1.  HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy.

Authors:  Claudio Puoti
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

2.  Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.

Authors:  B Kallinowski; K Haseroth; G Marinos; C Hanck; W Stremmel; L Theilmann; M V Singer; S Rossol
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.

Authors:  M M Jamal; A Soni; P G Quinn; D E Wheeler; S Arora; D E Johnston
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

Review 4.  Cytokines in viral hepatitis.

Authors:  M J Koziel
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

5.  Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection.

Authors:  S Sobue; T Nomura; T Ishikawa; S Ito; K Saso; H Ohara; T Joh; M Itoh; S Kakumu
Journal:  J Gastroenterol       Date:  2001-08       Impact factor: 7.527

6.  Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.

Authors:  Miguel A Rico; Juan A Quiroga; Dolores Subirá; Esteban Garcia; Susana Castañón; Matti Sällberg; Geert Leroux-Roels; Ola Weiland; Margarita Pardo; Vicente Carreño
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

7.  Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.

Authors:  P Mathurin; J Moussalli; J F Cadranel; V Thibault; F Charlotte; P Dumouchel; A Cazier; J M Huraux; B Devergie; M Vidaud; P Opolon; T Poynard
Journal:  Hepatology       Date:  1998-03       Impact factor: 17.425

8.  Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis.

Authors:  Manuela G Neuman; J P Benhamou; I M Malkiewicz; A Ibrahim; D C Valla; M Martinot-Peignoux; T Asselah; M Bourliere; G G Katz; N H Shear; P Marcellin
Journal:  J Viral Hepat       Date:  2002-03       Impact factor: 3.728

9.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.

Authors:  H M Diepolder; R Zachoval; R M Hoffmann; E A Wierenga; T Santantonio; M C Jung; D Eichenlaub; G R Pape
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

10.  Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha.

Authors:  Michael Frese; Kerstin Barth; Artur Kaul; Volker Lohmann; Verena Schwärzle; Ralf Bartenschlager
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

View more
  1 in total

1.  Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Hepat Res Treat       Date:  2011-06-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.